drugset / Trial / NCT02275845

Medico-GDM Trial - Metformine to Prevent Gestational Diabetes Mellitus

NCT02275845 ↗

Phase 3 Unknown 400 enrolled Maasstad Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

Metformin vs Control to prevent gestational diabetes mellitus (GDM) in women with a high risk for GDM, an open label randomized controlled trial' The Medico-GDM trial

Timeline

Start
2014-09
Primary completion
2016-09
Completion
2017-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1000 mg —

Indications